Movement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness

Market Focus06-11 09:58

On June 11, Insilico Medicine fell 5.01% in regular trading, trading at 31.52 HKD/share, with trading volume of 24.78 million HKD. The decline marks the fourth consecutive session of over 5% losses as the company faces a convergence of negative catalysts.

On the news front, the cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares facing unlock — representing 81.25% of total share capital. With the current price still carrying a premium over the IPO price, market concerns over concentrated selling pressure continue to intensify. Fundamentally, the company reported revenue declining 34.48% year-over-year with a net loss attributable to shareholders of USD 352 million, leaving no earnings inflection point in sight.

Within the Life Sciences Tools and Services sector, the overall tone remained soft. Among peers, WUXI XDC fell 3.45%, XtalPi fell 2.73%, and WUXI BIO fell 0.81%, with sector-wide weakness further dampening sentiment around Insilico Medicine.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165934834?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 09:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165934834","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness","media":"Market Focus","content":"<p><p>On June 11, Insilico Medicine fell 5.01% in regular trading, trading at 31.52 HKD/share, with trading volume of 24.78 million HKD. The decline marks the fourth consecutive session of over 5% losses as the company faces a convergence of negative catalysts.</p><p>On the news front, the cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares facing unlock — representing 81.25% of total share capital. With the current price still carrying a premium over the IPO price, market concerns over concentrated selling pressure continue to intensify. Fundamentally, the company reported revenue declining 34.48% year-over-year with a net loss attributable to shareholders of USD 352 million, leaving no earnings inflection point in sight.</p><p>Within the Life Sciences Tools and Services sector, the overall tone remained soft. Among peers, WUXI XDC fell 3.45%, XtalPi fell 2.73%, and WUXI BIO fell 0.81%, with sector-wide weakness further dampening sentiment around Insilico Medicine.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Falls 5.01% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Fundamental Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-11 09:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 11, Insilico Medicine fell 5.01% in regular trading, trading at 31.52 HKD/share, with trading volume of 24.78 million HKD. The decline marks the fourth consecutive session of over 5% losses as the company faces a convergence of negative catalysts.</p><p>On the news front, the cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares facing unlock — representing 81.25% of total share capital. With the current price still carrying a premium over the IPO price, market concerns over concentrated selling pressure continue to intensify. Fundamentally, the company reported revenue declining 34.48% year-over-year with a net loss attributable to shareholders of USD 352 million, leaving no earnings inflection point in sight.</p><p>Within the Life Sciences Tools and Services sector, the overall tone remained soft. Among peers, WUXI XDC fell 3.45%, XtalPi fell 2.73%, and WUXI BIO fell 0.81%, with sector-wide weakness further dampening sentiment around Insilico Medicine.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1165934834","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165934834","pubTimestamp":1781143111,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 11, Insilico Medicine fell 5.01% in regular trading, trading at 31.52 HKD/share, with trading volume of 24.78 million HKD. The decline marks the fourth consecutive session of over 5% losses...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动向提示|英矽智能常规交易跌5.01%大规模禁售到期倒计时加剧基本面疲弱","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On June 11, Insilico Medicine fell 5.01% in regular trading, trading at 31.52 HKD/share, with trading volume of 24.78 million HKD. The decline marks the fourth consecutive session of over 5% losses as the company faces a convergence of negative catalysts.On the news front, the cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, with approximately 453 million shares facing unlock — representing 81.25% of total share capital. With the current price still carrying a premium over the IPO price, market concerns over concentrated selling pressure continue to intensify. Fundamentally, the company reported revenue declining 34.48% year-over-year with a net loss attributable to shareholders of USD 352 million, leaving no earnings inflection point in sight.Within the Life Sciences Tools and Services sector, the overall tone remained soft. Among peers, WUXI XDC fell 3.45%, XtalPi fell 2.73%, and WUXI BIO fell 0.81%, with sector-wide weakness further dampening sentiment around Insilico Medicine.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165934834","isCrawlerRequest":true}